Saxagliptin Production Cost Reports

The report provides a detailed analysis essential for establishing a Saxagliptin production plant. It encompasses all critical aspects necessary for Saxagliptin production, including the cost of Saxagliptin production, Saxagliptin plant cost, Saxagliptin production costs, and the overall Saxagliptin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Saxagliptin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Saxagliptin is a medication primarily used in the pharmaceutical industry as an active pharmaceutical ingredient (API) for treating type 2 diabetes mellitus. Its industrial applications focus on large-scale production of oral antidiabetic medications, including standalone and combination tablets with agents like metformin. Additionally, saxagliptin plays a significant role in pharmaceutical research and development, where it is utilised to explore new formulations, delivery methods, and combination therapies. It is also used in academic and clinical studies to investigate diabetes treatment outcomes and safety.

The saxagliptin market is primarily driven by the rising global prevalence of type 2 diabetes, fuelled by factors like sedentary lifestyles, unhealthy diets, ageing populations, and increasing obesity rates. This growing patient population creates strong demand for effective diabetes management options, positioning saxagliptin as a preferred treatment choice.Additional market drivers include continuous pharmaceutical R&D efforts to improve drug delivery systems and develop combination therapies to enhance treatment outcomes.

Moreover, expanding healthcare access, especially in emerging markets like the Asia-Pacific and Latin America, and growing government healthcare spending contribute to market growth. Patent expirations enabling generic drug availability further increase accessibility and affordability, which boosts the market demand. However, high purity, batch-to-batch consistency, and stability of the API are critical for industrial saxagliptin procurement, ensuring compliance with drug formulation and safety standards.

Raw Material for Saxagliptin Production

According to the Saxagliptin production plant project report, the raw material for Saxagliptin production includes N-Boc-hydroxyadamantylglycine.

Production Process of Saxagliptin

The extensive Saxagliptin production cost report consists of the following major industrial production process:

1. Production via chemical synthesis: The production process of saxagliptin involves a few key chemical synthesis steps. In the first step, N-Boc-hydroxyadamantylglycine is coupled to (1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide (TFA salt) under standard acylation conditions using EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride) and HOBt (1-hydroxybenzotriazole), yielding a dipeptide amide intermediate in high yield. This intermediate is then dehydrated with trifluoroacetic anhydride (TFAA), followed by an in situ basic hydrolysis of the resulting trifluoroacetate, and a subsequent Boc group deprotection that leads to the production of saxagliptin.

Properties of Saxagliptin

Saxagliptin is a white to off-white, non-hygroscopic crystalline solid with the molecular formula C18H25N3O2 and a molecular weight of 315.41 g/mol (anhydrous form). It has a melting point between 103-107 degree Celsius and an estimated boiling point around 548.7 degree Celsius. The compound is temperature sensitive and shows slight solubility in DMSO and sparing solubility in methanol, with a water solubility of 2.26 mg/mL. Saxagliptin features two hydrogen bond donors and four acceptors, with a topological polar surface area of about 90.35 Ų and a calculated logP (lipophilicity) near 0.7-0.88, indicating moderate hydrophilicity. Its pKa is roughly 7.3 to 15.1 (varies with measurement conditions). The hydrochloride salt form (saxagliptin hydrochloride) is also commercially available and used in formulations to improve solubility and stability.